Regulation of tumor angiogenesis by the microtubule-binding protein CLIP-170

[1]  K. Gelmon,et al.  Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials. , 2012, Cancer treatment reviews.

[2]  Xiaodong Sun,et al.  Inhibition of farnesyltransferase reduces angiogenesis by interrupting endothelial cell migration. , 2012, Biochemical pharmacology.

[3]  Jun Zhou,et al.  Regulation of Vascular Endothelial Cell Polarization and Migration by Hsp70/Hsp90-Organizing Protein , 2012, PloS one.

[4]  R. Aneja,et al.  Cep70 contributes to angiogenesis by modulating microtubule rearrangement and stimulating cell polarization and migration , 2012, Cell cycle.

[5]  Min Liu,et al.  Microtubule‐binding protein CLIP‐170 is a mediator of paclitaxel sensitivity , 2012, The Journal of pathology.

[6]  D. Cheresh,et al.  Tumor angiogenesis: molecular pathways and therapeutic targets , 2011, Nature Medicine.

[7]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[8]  Min Liu,et al.  Microtubule-associated deacetylase HDAC6 promotes angiogenesis by regulating cell migration in an EB1-dependent manner , 2011, Protein & Cell.

[9]  Min Liu,et al.  Ectopic expression of the microtubule‐dependent motor protein Eg5 promotes pancreatic tumourigenesis , 2010, The Journal of pathology.

[10]  Dengwen Li,et al.  CYLD regulates angiogenesis by mediating vascular endothelial cell migration. , 2010, Blood.

[11]  Li Fu,et al.  Oncogenic function of microtubule end‐binding protein 1 in breast cancer , 2010, The Journal of pathology.

[12]  N. Harbeck,et al.  Angiogenesis inhibitors in the management of breast cancer , 2010, Current opinion in obstetrics & gynecology.

[13]  Min Liu,et al.  Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule‐dependent mechanism , 2009, The Journal of pathology.

[14]  G. Gundersen,et al.  Beyond polymer polarity: how the cytoskeleton builds a polarized cell , 2008, Nature Reviews Molecular Cell Biology.

[15]  M. Bornens.  Organelle positioning and cell polarity , 2008, Nature Reviews Molecular Cell Biology.

[16]  Chunyong Liu,et al.  EB1 promotes Aurora-B kinase activity through blocking its inactivation by protein phosphatase 2A , 2008, Proceedings of the National Academy of Sciences.

[17]  Katsuo Suzuki,et al.  Regulation of lamellipodia formation and cell invasion by CLIP-170 in invasive human breast cancer cells. , 2008, Biochemical and biophysical research communications.

[18]  Anna Akhmanova,et al.  Tracking the ends: a dynamic protein network controls the fate of microtubule tips , 2008, Nature Reviews Molecular Cell Biology.

[19]  J. Folkman.  Opinion: Angiogenesis: an organizing principle for drug discovery? , 2007, Nature Reviews Drug Discovery.

[20]  J. Huot,et al.  Endothelial cell migration during angiogenesis. , 2007, Circulation research.

[21]  Jun Noritake,et al.  Regulation of microtubules in cell migration. , 2005, Trends in cell biology.

[22]  S. Chae,et al.  Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. , 2004, The Journal of clinical investigation.

[23]  C. Waterman-Storer,et al.  Conserved microtubule–actin interactions in cell movement and morphogenesis , 2003, Nature Cell Biology.

[24]  V. Diehl,et al.  Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma. , 1992, Blood.

[25]  J. Delabie,et al.  Restin: a novel intermediate filament‐associated protein highly expressed in the Reed‐Sternberg cells of Hodgkin's disease. , 1992, The EMBO journal.

[26]  Miguel Vicente-Manzanares,et al.  Cell migration: an overview. , 2011, Methods in molecular biology.

[27]  A. Akhmanova,et al.  Cell and molecular biology of microtubule plus end tracking proteins: end binding proteins and their partners. , 2010, International review of cell and molecular biology.

[28]  J. Folkman.  Angiogenesis: an organizing principle for drug discovery? , 2007, Nature reviews. Drug discovery.